FDA Approved: INVELTYS — Supplemental Application (ALCON LABORATORIES, INC.)

View source ↗

Summary

The FDA approved a supplemental application for INVELTYS (loteprednol etabonate) from Alcon Laboratories, Inc. The action likely involves labeling changes or th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Ocular Inflammation
• Postoperative Ocular Pain

Drugs mentioned

• INVELTYS (LOTEPREDNOL ETABONATE)

Snippet

SUPPL AP for INVELTYS (LOTEPREDNOL ETABONATE)